510(k) Report

510(k) · Cleared

Recalled · Class II · 2016

Philips Spectral CT Applications

K150665510(k) TraditionalCleared Aug 7, 2015144-day reviewClass II21 CFR 892.1750Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Philips Medical Systems Nethrlands BV · JAK System, X-Ray, Tomography, Computed

Cleared on Aug 7, 2015 as substantially equivalent to K133674 (Philips Healthcare (Cleveland), 2014) after a 144-day review. Its family tree reaches back 8 generations to 1993. 1 later device descends from it. It has been recalled once.

Decided
Aug 7, 2015
Review
144 days
Class
Class II
Product code
JAK
Recalls
1
Predicates
1

Its longest line of descent runs back 8 generations to K930090 (1993). 13 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 8 generations backK930090 HelicatElscint, Inc. · 1993
  2. 7 generations backK961464 Select/SPElscint, Inc. · 1996 · Recalled
  3. 6 generations backK982060 Volumax CT Imaging SystemElscint, Inc. · 1998
  4. 5 generations backK012009 MX8000 Idt CT SystemMarconi Medical Systems, Inc. · 2001 · Recalled
  5. 4 generations backK033326 Philips Plus Computed Tomography SystemPhilips Medical Systems, Inc. · 2003 · Recalled
  6. 3 generations backK060937 Brilliance VolumePhilips Medical Systems (Cleveland), Inc. · 2006 · Recalled
  7. 2 generations backK131773 Brilliance IctPhilips Healthcare (Cleveland) · 2013
  8. 1 generation backK133674 Philips Iqon Spectral CTPhilips Healthcare (Cleveland) · 2014 · Recalled
  9. This deviceK150665 Philips Spectral CT ApplicationsPhilips Medical Systems Nethrlands BV · 2015
  10. Descendant · cites it directly · 0 of its ownK260169 AV Cardiac CTPhilips Medical Systems Nederland B.V. · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K260169AV Cardiac CTPhilips Medical Systems Nederland B.V. · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K930090HelicatElscint, Inc.1993—
−7K961464Select/SPElscint, Inc.19963
−6K982060Volumax CT Imaging SystemElscint, Inc.1998—
−5K012009MX8000 Idt CT SystemMarconi Medical Systems, Inc.200161
−4K033326Philips Plus Computed Tomography SystemPhilips Medical Systems, Inc.2003131
−3K060937Brilliance VolumePhilips Medical Systems (Cleveland), Inc.200661
−2K131773Brilliance IctPhilips Healthcare (Cleveland)2013—
−1K133674Philips Iqon Spectral CTPhilips Healthcare (Cleveland)20146
0 (this device)K150665Philips Spectral CT ApplicationsPhilips Medical Systems Nethrlands BV2015—
+1K260169AV Cardiac CTPhilips Medical Systems Nederland B.V.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199420
199510
199710
200110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K150665, 1993–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JAK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JAK device

  1. #1 K230223 iCAC Devicescore 23.5 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K133674Philips Iqon Spectral CT
Summary page 4
…n: 21 CFR 892.1750 Class: II Product Code: JAK, LLZ Panel: Radiology Predicate devices IQon Spectral CT (K133674) EBW NM 2.0 (K111336) Brilliance iCT (K060937) Premarket Notification [510(…
Philips Healthcare (Cleveland)20146
†K060937Brilliance VolumePhilips Medical Systems (Cleveland), Inc.200661
†K111336EBW NM 2.0Philips Medical Systems (Cleveland), Inc.2011—

Also cleared against K133674: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K260169AV Cardiac CTPhilips Medical Systems Nederland B.V.20260

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Nov 14, 2016Class IIZ-0706-2017Software designA software defect is causing issues with the IQon Spectral CT and Philips Spectral CT Applications while filming, saving and annotating images

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 6 companies; a new generation was cleared every 2.6 years on median.
  • 6 of the 13 ancestors have a recall of any class.
  • Of its descendants, K260169 (Philips Medical Systems Nederland B.V., 2026) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K133674.

How does its category compare?

All JAK devices

JAK System, X-Ray, Tomography, Computed: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · JAK

27in 2025

2007: 142008: 262009: 152010: 72011: 162012: 282013: 172014: 302015: 302016: 252017: 292018: 242019: 282020: 302021: 202022: 302023: 272024: 262025: 272026 (partial year): 21
2007high 30 (2014) · low 7 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JAK

141in 2025

2007: 27 days median2008: 42 days median2009: 31 days median2010: 92 days median2011: 155 days median2012: 121 days median2013: 132 days median2014: 200 days median2015: 140 days median2016: 129 days median2017: 96 days median2018: 114 days median2019: 94 days median2020: 112 days median2021: 145 days median2022: 131 days median2023: 139 days median2024: 141 days median2025: 141 days median2026 (partial year): 167 days median
2007high 200 (2014) · low 27 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JAK

17in 2025

2007: 112008: 162009: 292010: 512011: 342012: 232013: 112014: 102015: 282016: 442017: 332018: 102019: 52020: 82021: 152022: 92023: 92024: 202025: 172026 (partial year): 23
2007high 51 (2010) · low 5 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JAK

219in 2025

2007: 762008: 1202009: 1052010: 1192011: 2052012: 1922013: 4142014: 3082015: 4542016: 3652017: 3382018: 5432019: 2332020: 1772021: 2612022: 1992023: 3102024: 2122025: 219
2007high 543 (2018) · low 76 (2007)2025

MAUDE reports naming product code JAK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200714271176
2008264216120
2009153129105
201079251119
20111615534205
20122812123192
20131713211414
20143020010308
20153014028454
20162512944365
2017299633338
20182411410543
201928945233
2020301128177
20212014515261
2022301319199
2023271399310
20242614120212
20252714117219
20262116723—

What is it indicated for?

The Philips Spectral CT Applications support viewing and analysis of images at energies selected from the available spectrum in order to provide information about the chemical composition of the body materials and/or contrast agents. The Spectral CT Applications provide for the quantification and graphical display of attenuation, material density, and effective atomic number. This information may be used by a trained healthcare professional as a…

Read the full statement (145 words)

The Philips Spectral CT Applications support viewing and analysis of images at energies selected from the available spectrum in order to provide information about the chemical composition of the body materials and/or contrast agents. The Spectral CT Applications provide for the quantification and graphical display of attenuation, material density, and effective atomic number. This information may be used by a trained healthcare professional as a diagnostic tool for the visualization and analysis of anatomical and pathological structures.

The Spectral enhanced Advanced Vessel Analysis (sAVA) application is intended to assist clinicians in viewing and evaluating CT images, for the inspection of contrast-enhanced vessels.

The Spectral enhanced Comprehensive Cardiac Analysis (sCCA) application is intended to assist clinicians in viewing and evaluating cardiovascular CT images.

The Spectral enhanced Tumor Tracking (sTT) application is intended to assist clinicians in viewing and evaluating CT images, for the inspection of tumors.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K150665: Philips Spectral CT Applications.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K150665

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026